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Abstract This systematic review evaluates relevant
findings and methodologic aspects of studies on cognitive
functioning in meningioma patients prior to and/or fol-
lowing surgery with or without adjuvant radiotherapy.
PubMed and Web of Science electronic databases were
searched until December 2015. From 1012 initially iden-
tified articles, 11 met the inclusion criteria for this review.
Multiple methodological limitations were identified which
include the lack of pre-treatment assessments, variations in
the number and types of neuropsychological tests used, the
normative data used to identify patients with cognitive
deficits, and the variety of definitions for cognitive
impairment. Study results suggest that most of meningioma
patients are faced with cognitive deficits in several cogni-
tive domains prior to surgery. Following surgery, most of
these patients seem to improve in cognitive functioning.
However, they still have impairments in a wide range of
cognitive functions compared to healthy controls.
Suggestions are given for future research. Adequate diag-
nosis and treatment of cognitive deficits may ultimately
lead to improved outcome and quality of life in menin-
gioma patients.
Keywords Meningioma  Cognition 
Neuropsychological  Attention  Memory  Executive
functions  Neurosurgery  Radiotherapy
Introduction
As a result of increasingly effective disease management,
patients with brain tumors have better survival rates. This
prompts a different approach towards health care. Instead
of considering survival as the sole endpoint, quality of
survival is also considered [1]. The assessment of health
related quality of life (HRQoL) and cognitive function has
become increasingly recognized as an important outcome
measure in brain tumor research. Cognitive functioning has
a significant impact on HRQoL, and could even be a pre-
dictor of HRQoL [2].
To date, most studies on cognitive functioning in brain
tumor patients have focused on glioma patients. Less is
known about cognitive functioning in meningioma
patients and the impact of surgery and/or (adjuvant)
radiotherapy [3–10]. Rapidly growing tumor types such as
high-grade gliomas typically lead to more cognitive
impairment than slowly growing tumors such as menin-
giomas [11, 12]. However, even meningiomas can cause
cognitive deficits by putting pressure on brain tissue [13].
These tumors often grow to a considerable size before
clinical symptoms appear because of the plastic potential
of the brain [14–17].
The objective of this systematic review was to evaluate
the available data and the quality of studies on cognitive
impairment in meningioma patients prior to and/or fol-
lowing treatment, and to document potential changes in
cognitive dysfunction due to treatment (i.e., surgery with or
without adjuvant radiotherapy). We also reviewed methods
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used to evaluate cognitive function in meningioma
patients, and make recommendations for future studies.
Methodology (systematic review)
Inclusion criteria
This systematic review included peer-reviewed research
articles on cognitive functioning in adult patients with
meningioma prior to and/or following surgery with or
without adjuvant radiotherapy, as assessed with neuropsy-
chological tests.
Search strategy
Searches were conducted using the electronic databases of
PubMed (MEDLINE) and Web of Science (Web of
Knowledge). For each database, searches included the
terms: mening* or brain or cerebral or cranial (title/ab-
stract, topic), in addition, an ‘and’ condition was specified
for the following 2 groups of terms: (1) neuropsycholog* or
cognit* or neurocognit* or attention* or memory or exec-
utive function* (title), (2) tumor* or tumour* or neoplasm*
(title).
Searches were limited to adult human-beings and peer-
reviewed original research papers written in English. In
addition, results of studies that examined cognitive func-
tioning in groups of brain tumor patients were also inclu-
ded if separate analyses were done for meningioma patient
groups. Studies without objective measures of cognitive
function as assessed with neuropsychological tests were
excluded. Studies that used very short screening tests, such
as Mini-Mental State Examination (MMSE) and 3MS
examination (modified MMSE) were included, but are only
briefly discussed. There were no restrictions on publication
dates, and the final searches were done in December 2015.
Study selection process
In total, 2205 article citations (i.e., 873 in PubMed ? 1332
in Web of Science) were found and downloaded into
EndNote [18]. These were scanned using EndNote for
duplicates, and 1193 were deleted, yielding a final total of
1012 articles.
Then, the titles of these articles were sifted to exclude
all articles that did not meet the objectives of this review,
which resulted in the removal of 886 articles. This first sift
resulted in 126 articles for which abstracts and/or full text
articles were assessed in detail. Subsequently, 115 (out of
126) articles were rejected because they did not meet the
inclusion criteria, were conference presentations or case
reports. The remaining 11 articles were examined jointly
by 2 reviewers and remain included for this review.
Results
Table 1 summarizes the 11 studies that evaluated cognitive
functioning in meningioma patients prior to and/or fol-
lowing treatment. In this section, results from studies
including pre-operative and post-operative cognitive
assessments are discussed. The effects of adjuvant radio-
therapy on cognitive outcomes are discussed in a subse-
quent section. Potential associations of cognitive
impairment with tumor location and other factors are pre-
sented in Box 1.
Cognitive functioning in meningioma patients prior
to and/or following surgery
Cognitive functioning prior to treatment was examined in 5
studies with a total of 199 meningioma patients eligible for
surgery [4, 7, 10, 19, 20] (see Table 1). Overall, in these
studies, cognitive functioning has been found impaired.
Most commonly affected domains were memory, attention,
and executive functions. Cognitive functioning following
surgery was investigated in 7 studies including a total of
302 meningioma patients [4, 7–10, 19, 20] (see Table 1).
All studies, except 2 [8, 9], started with a pre-operative
assessment. Pre-operative assessments allow to determine
possible effects of surgery on cognitive performance. Only
2 [4, 20] of the 5 studies with a repeated (pre-and post-
operative) assessment of cognitive function controlled for
the influence of practice effects. In general, all studies
showed significant improvements following surgery in
cognitive functioning, mostly on memory, attention, and
executive function. There was no consistency in results
across studies with regard to the cognitive domains that did
not improve after surgery. However, despite cognitive
improvements, all studies (including those without pre-
operative assessment) demonstrated that patients (still) had
significantly lower scores in various cognitive domains
after surgery, compared to healthy controls. For studies
including a pre-and post-operative assessment (mean
interval between 2 assessments ranging from 3 to
9 months), no clear conclusions can be drawn on the effect
of time since surgery on the post-operative cognitive out-
come. Severity data (e.g., effect sizes, incidences) were not
available for most of them, due to differing populations.
In particular, Tucha and colleagues [4] found significant
pre-operative impairments in patients with frontal menin-
giomas (N = 54) on measures of working memory, atten-
tion, and executive functions (lower mean raw scores,
longer reaction times, or higher error rates), compared to
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No sign differences in cognitive status between lateralization groups prior to and following surgery Tucha [4]
Sign differences in changes over time between lateralization groups, mainly on attentional functions. Left-
sided (n = 22) MGM improved sign on flexibility and shifting. Right-sided (n = 21) MGM improved sign
on variety of attentional functions
Sign effect of frontal MGM on pre-operative and post-operative cognitive status. Prior to surgery; falx
cerebri (n = 14) performed sign better on figural fluency than frontobasal (n = 19) and convexity (n = 17)
MGM. Following surgery; frontobasal (n = 19) and falx cerebri (n = 14) MGM performed sign better on
divided attention and figural memory than convexity (n = 17) MGM
Sign differences between localization groups for various cognitive domains. Convexity (n = 17) MGM: only
improvement on flexibility and shifting (attentional/executive functions), frontobasal (n = 19) MGM:
improvement on a broader range of attentional/executive functions after surgery. Pts with falx cerebri (n =
14) MGM improved on various cognitive domains
No sign differences in cognitive status between lateralization groups prior to and following surgery Meskal [20]
No sign associations between tumor lateralization and cognitive improvement over time
No sign differences in pre-operative or post-operative cognitive functioning based on tumor localization,
except for complex attention: sign better performance for infratentorial (n = 7) as opposed to supratentorial
(n = 61) tumors
No sign associations between tumor localization (skull base, convexity, and convexity/falx) and cognitive
improvement over time
Cognitive function normalized in right-sided (n = 17) MGM following surgery. Left-sided (n = 17) MGM did
not normalize or improve
Yoshii [7]
No statistical tests were conducted in this study: no clear conclusions can be drawn
No reports on specific localization or lateralization effects on cognitive functioning Koizumi [19]
Based on data in a table; 3 pts with very low scores (\10) on MMSE before surgery, suffered from convexity
(n = 4) MGM. These pts improved substantially after surgery, but still had the lowest scores on MMSE (B
23), compared with other localization groups
No clear associations of memory functions with localization before FSRT (no data reported) Steinvorth [27]
No clear lateralization effects before and after FSRT
Pts with left-sided (n = 37) MGM performed sign worse on verbal memory compared to right-sided (n = 25)
MGM
Dijkstra [5]
Lower cognitive performance in skull-base (n = 24) MGM on verbal memory, information processing, and
psychomotor speed compared to convexity (n = 28) MGM. Not clear as to whether theses analyses were
done in smaller subgroups of the study sample
Epilepsy Sign negative correlation between epilepsy burden and executive functioning, primarily due to AEDs use,
not to epileptic seizures
Dijkstra [5]
Sign impaired cognitive functioning also in pts who did not use AEDs (n = 66) compared with HC
Comparable HRQoL in pts to that in HC Waagemans [2]
HRQoL worse in pts with cognitive deficits and pts who use AEDs, irrespective of seizure control
Mood No sign correlation between anxiety and cognitive domains, negative correlation between depression and 6/7
cognitive domains prior to surgery (n = 60 out of 68)
Meskal [20]
Negative correlation between anxiety and attention, negative correlation between depression, memory and
attention following surgery (n = 52 out of 62)
Sign improvement toward a positive mood from baseline (no data reported) up to 6 weeks after follow-up of
FSRT
Steinvorth [27]
No correlations were investigated
Quality of
life
RTx? pts lower HRQoL than RTx- pts Van
Nieuwenhuizen
[8]
No sign differences in HRQoL between RTx- pts and HC. After correction for duration of disease, no sign
differences in HRQoL between both MGM groups
No comparisons were made for HRQoL between RTx? pts and HC
No sign differences between pts and HC on 7/8 HRQoL scales Waagemans [2]
Impaired executive functioning had a direct negative relationship with other cognitive domains (information
processing, verbal memory, psychomotor speed, and attention), and an indirect negative relationship with
HRQoL
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healthy controls (matched for age, gender, educational
level, handedness, and intelligence). After surgery, signif-
icant improvements were observed on measures of memory
and attention. However, despite these significant
improvements, patients’ post-operative status remained
significantly impaired in attention and executive functions,
compared to healthy controls who were retested over the
same intervals. According to the authors, only the better
post-operative performance in figural memory (immediate
recall) could be partly explained by practice effects by
comparing the test results with the healthy control group.
Note that the authors classified flexibility and shifting as
subdomains of attention. However, these measures can also
be considered as components of executive functioning [21].
In addition, Tucha and colleagues [10] conducted a
study with elderly meningioma patients (N = 33). These
patients showed significant pre-operative impairments on
measures of working memory, short-term figural memory,
attention, and executive functions (lower mean raw scores,
longer reaction times, or higher error rates), compared to
healthy controls in the same age-range. After surgery,
significant improvements were observed on measures of
memory and attention, with the exception of working
memory. In this study, patients’ post-operative cognitive
status corresponded with the cognitive functioning of the
healthy control group (except for working memory).
Because the healthy controls were only tested once, it was
not possible to rule out practice effects, which may have
masked lower performance in the elderly meningioma
patients. See the above-mentioned note regarding the
classification of cognitive domains by these authors. It was
not reported if there was overlap in patients between these
2 studies by Tucha and colleagues; a certain amount of
overlap between the patient samples seems possible [4, 10].
In a recent study by Meskal and colleagues [20],
meningioma patients (N = 68) had significantly lower
mean pre-operative and post-operative standard scores on
measures of memory, psychomotor speed, reaction time,
complex attention, cognitive flexibility, processing speed,
and executive functioning, compared to (American) nor-
mative data as provided by the Central Nervous System
Vital Signs battery (i.e. CNS VS), a brief (30 min)
computerized battery of neuropsychological tests [22].
Forty-seven out of 68 patients (69 %) scored low or very
low on 1 or more cognitive domains. After surgery, sig-
nificant improvements were observed on all cognitive
domains, with the exception of psychomotor speed and
reaction time. Twenty-seven out of 62 patients (47 %),
scored low or very low on 1 or more cognitive domains
after surgery.
The 3MS test used in a study by Yoshii and colleagues
[7] showed a subnormal function (mean 3MS score\ 85)
in 34 meningioma patients pre-operatively. Cognitive
function normalized after surgery only in patients with
right-sided (n = 17) meningioma (post-surgery mean 3MS
score[ 85). Note that the authors have chosen for a more
stringent cut-off of 85 instead of 77/78, which is generally
used as cut-off for cognitive impairment [23]. In addition,
patients were tested within 1 month after surgery, which is
a very short follow-up time that may identify (more severe)
transitory cognitive problems instead of persistent cogni-
tive deficits in left-sided meningioma patients. Further-
more, it was not clearly described by the authors why some
patients had only 1 assessment (i.e., prior to, or following
surgery), and other patients were assessed twice with the
3MS test (prior to, and following surgery).
Another study, by Koizumi and colleagues [19], evalu-
ated cognitive dysfunction with the MMSE in meningioma
patients (N = 10) who also underwent 123I-Iomazenil
(IMZ) single-photon emission computed tomography
(SPECT) imaging. The mean pre-operative MMSE scores
were 19.9 ± 11.4; ranging from 2 to 30. The MMSE cut-
off points for normal, mild, moderate, and severe cognitive
impairment were not described by the authors. Based on
the MSSE cut-off levels application by Folstein and col-
leagues [24], 3 patients had moderate to mild cognitive
impairment (scores on MMSE ranging from 20 to 25), and
3 patients had severe cognitive impairment (scores ranging
from 2 to 5); 4 of them had scores of 29–30. Overall, 6
patients scored above the cut-off point of 23. After surgery,
a significant improvement in cognitive function (mean
post-surgery MMSE: 26.5 ± 3.8) was found. Seven of the
10 patients scored above the cut-off of 23 on the MMSE,







IZM-SPECT images showed recovered binding potential of IZM following surgery Koizumi [19]
AEDs anti-epileptic drugs, FSRT fractioned stereotactic radiotherapy, HC healthy controls, HRQoL health-related quality of life, IZM-SPECT
133I-iomazenil (IMZ) single-photon emission computed tomography (SPECT) imaging. MGM meningioma, MMSE mini-mental state exami-
nation, Pts patients, RTx radiotherapy. Sign significant
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patients. Note that screening tests such as the MMSE and
3MS are not sensitive enough to discriminate between mild
cognitive impairment and normal cognitive functioning
[25].
Van Nieuwenhuizen and colleagues [6] found signifi-
cantly lower mean Z-scores in patients with a wait-and-
scan policy (N = 21) on measures of psychomotor speed
and working memory, compared to normative matched
healthy controls from the Maastricht Aging Study (i.e.,
MAAS [26]). Note that this study was conducted in a
specific group of meningioma patients, in which the tumor
was small, growing slowly, and was not causing symptoms
or if surgery carried too many risks, particular for older
patients who are more vulnerable to develop complications
after surgery due to their medical condition.
Steinvorth and colleagues [27] included 10 patients
admitted only for fractioned stereotactic radiotherapy
(FSRT) instead of surgery. However, the authors did not
report cognitive results. Note that the patients who were
included in the studies by Van Nieuwenhuizen and col-
leagues [6] and Steinvorth and colleagues [27] were sub-
stantially different (e.g., smaller tumor volumes, inoperable
meningiomas after subtotal resection or recurrence) from
those patients who were admitted for surgical treatment.
Therefore, the results of the aforementioned 2 studies
cannot be generalized to the general population of
meningioma patients admitted for surgery.
In another study by Van Nieuwenhuizen and colleagues
[8] in which some (n = 18) meningioma patients were
tested only after surgery and not before, significantly lower
mean standard scores were found on a number of verbal
memory subtests, compared to normative healthy controls.
The authors concluded that these patients had significantly
lower cognitive functioning than healthy controls. Atten-
tion and executive function were not impaired in these
patients. The patients of this study were compared with
patients (n = 18) who received adjuvant radiotherapy after
surgery (RTx?). The results of the latter patient group are
discussed in the section on effects of adjuvant radiotherapy.
It should be noted that although overlap in patients between
this study and the above-mentioned study of Van
Nieuwenhuizen cannot be ruled out, this is not likely since
the study in patients who had already undergone surgery
[8] preceded the study in patients in whom surgery was not
performed [6].
Similar to the aforementioned study, Krupp and col-
leagues [9] investigated cognitive functioning after surgery
without a pre-operative assessment in 91 patients. Com-
pared with published normative population values, major
deficits in attention appeared in patients of approximately
55 years of age, worsening in patients with increasing age.
Significant negative correlations were found between age
and attention performance in patients older than 55, as well
as with the intelligence factors verbal knowledge, technical
ability, and word fluency. No such correlation was found
for reasoning and age. Since no pre-treatment assessment
was available in the aforementioned 2 studies, the specific
effects of the brain tumor or surgery on cognitive perfor-
mance cannot be determined.
Cognitive functioning in meningioma patients:
effects of adjuvant radiotherapy
Three studies investigated cognitive functioning in
meningioma patients who had undergone radiotherapy
after surgery [2, 5, 8]. These studies described the same [2,
5] or an overlapping ([8]) patient sample, but investigated
different types of research questions. In these studies,
patients in whom the tumor could only be partially resected
and patients with a recurrence after surgery received
adjuvant radiotherapy.
The study by Van Nieuwenhuizen and colleagues [8]
investigated the exclusive effects of adjuvant radiotherapy
after surgery by comparing patients who had surgery only
(RTx-) with patients who had surgery and adjuvant
radiotherapy (RTx?). The authors found no significant
differences in mean standard scores on all cognitive mea-
sures (memory, attention, executive function, and percep-
tion) between RTx- (n = 18) and RTx? (n = 18) patients
(which may be patients with different tumor characteris-
tics). No comparisons were made for cognitive functioning
between the RTx? group and healthy controls. In this
study, additional radiotherapy did not have deleterious
effects on cognitive functioning. The studies by Dijkstra
and colleagues [5] and Waagemans and colleagues [2] did
not differentiate between the effects of surgery and/or
radiotherapy. In the study by Dijkstra and colleagues [5],
patients (N = 89) showed significantly lower mean
Z-scores on measures of verbal memory, visual memory,
working memory, information processing, psychomotor
speed, and executive function (most impaired), compared
to normative matched healthy controls (from MAAS [26]).
No significant differences were found for attention. Note
that the proportions of patients with cognitive deficits
(defined as 1.5 SD below the mean of a matched control
group) was not reported by these authors. The study by
Waagemans and colleagues [2] focused on HRQoL and
reported similar findings on cognitive functioning in
meningioma patients (N = 89) as in the study by Dijkstra
and colleagues [5]. A common limitation of the afore-
mentioned studies was an absence of a pre-treatment
assessment of cognitive functioning. Also noteworthy is
the large standard deviation (SD) of tumor volumes in
these studies.
Only 1 study [27] investigated the effects of FSRT
following surgery in meningioma patients (n = 30). In this
202 J Neurooncol (2016) 128:195–205
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study, cognitive function was evaluated before and after
FSRT. Patients had normal mean percentile scores, except
for a slow information processing speed prior to radio-
therapy. After the first fraction, a transient decline in
memory and, at the same time, improvements in attentional
functions were observed. No deteriorations were seen
during the further follow-up, but further increases in
memory and attention were observed. Note that the
improvement in attention was considered as a practice
effect, since a comparable improvement was also observed
in a control group, included in an earlier report by these
authors [27].
Conclusion and recommendations
This systematic review provides an overview of studies
investigating cognitive functioning in meningioma patients
prior to and/or following surgery with or without adjuvant
radiotherapy.
Drawing conclusions from studies and comparison of
results between them were complicated by several
methodological limitations, such as a lack of pre-treatment
assessments, variations in the number and types of neu-
ropsychological tests used, definitions of cognitive
impairment, quality of normative data, and absence of
control for practice effects.
Specific effects of treatment cannot be determined in the
absence of an assessment before treatment. The number of
patients with above average cognitive abilities before
treatment may be underestimated. Patients may have a
functional decline, but still perform within normal ranges
on cognitive tests. In addition, cognitive deficits that have
been present before treatment may be unjustly attributed to
surgery. None of the studies described the presenting
symptoms of the meningioma patients included. Therefore,
it is not clear if cognitive complaints were present at
neuropsychological assessment. As the cognitive status of
patients with incidentally-detected meningiomas is likely
to differ from that in patients presenting with cognitive
complaints, it is not clear as to whether the samples were
representative of all meningioma patients.
In addition, the number and types of neuropsychological
tests used, varied across studies and complicated compar-
ison of results. For example, 8 studies [2, 4–6, 8–10, 27]
tested patients with a traditional neuropsychological bat-
tery that consisted of 2 to 12 paper-and-pencil tests. One
study used a computerized screening battery (i.e., CNS VS
[22]) consisting of 7 neuropsychological tests [20]. Two
studies [7, 19] used very global screening tests (i.e., MMSE
and 3MS), that are known to have a low sensitivity and are
not useful for screening for subtle cognitive impairment
[25].
Quality of normative data also differed between studies,
2 studies included their own healthy control group matched
on different variables [4, 10], 4 studies used normative
matched data from 18 to 89 healthy controls from the
Maastricht Aging Study (MAAS [26]) [2, 5, 6, 8], and 5
studies used (published) normative healthy population
values as provided by the test (manual) [7, 9, 19, 20, 27].
Further, definitions used to classify patients as having
cognitive impairment differed across studies. Three studies
[2, 5, 6] used Z-scores and defined individual cognitive
impairment as 1.5 SD below the mean of a matched control
group. One study [20] defined standard scores of 1.5 and 2
SD below the mean of a normative control group as cog-
nitive impairment. Five studies [4, 8–10, 27] did not use a
definition of individual cognitive impairment. None of the
studies reported a cut-off for (general) cognitive impair-
ment on the number of tests required to be in an impaired
range. Only 1 study [20] reported on the incidence and
severity of cognitive impairment.
Finally, only 2 [4, 20] of the 5 studies with a pre-and
post-treatment assessment considered the influence of
practice effects on improved cognitive function after
repeated testing by including a (matched) control group
that was tested twice with the same test battery. The
computerized test battery CNS VS is assumed to be suit-
able for repeated testing because of the random presenta-
tion of stimuli [20, 22]. However, despite the chance that a
patient gets the same stimuli twice is negligible, there still
could be a learning effect of the battery in general, also
known as test-wiseness [28]. The patient knows what to
expect the second time. Thus, longitudinal studies without
consideration of practice effects may report better results
due to repeated exposure to neuropsychological testing.
Practice effects may therefore mask cognitive decline or
stability.
Moreover, many studies reviewed here lacked a clear
description of statistical testing, or only very basic statis-
tical analyses were conducted. For example, some studies
only performed univariate analyses where no correction for
potential other differences between groups was applied
when comparing effects of tumor localization (among
groups).
To overcome some of the methodological issues
described, we recommend using a test battery with a wide
range of neuropsychological tests that is sensitive enough
for identifying subtle cognitive impairment in patients and
suitable for serial repetition. In addition, a pre-treatment
assessment, a sufficiently large sample size to conduct
(multivariate) analyses, a uniform definition of cognitive
impairment, and appropriate quality of normative data are
suggested.
Despite these limitations, the studies in this review
demonstrate that meningioma patients have impaired
J Neurooncol (2016) 128:195–205 203
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cognitive functioning prior to treatment. In general, most
commonly affected domains were memory, attention, and
executive functions. Surgery generally had a beneficial
effect on cognitive function. A significant improvement in
cognitive functioning was found 3 to 9 months following
surgery, mostly on memory, attention, and executive
function. Cognitive performance still remained below nor-
mal however. There is no consistency across studies about
the domains that did not improve after surgery. In the one
study on adjuvant radiotherapy, no additional deleterious
effects on cognitive functioning at least 1 year after surgery
were found. Two other studies found that the use of AEDs
negatively affects cognitive functioning and HRQoL.
Mixed findings were reported with respect to effects of
lateralization and localization of the tumor on cognitive
impairment. In most studies, associations between cogni-
tive functioning and other tumor characteristics (i.e., vol-
ume, edema) were not observed [2, 4, 5] or could not be
made because of the small sample sizes in the studies [6].
Other factors that are known to have a relation to cognitive
performance prior to and/or following treatment, such as
epilepsy, mood, and HRQoL were not systematically
investigated across studies.
There is evidence to conclude that meningioma patients
are faced with cognitive dysfunction in several cognitive
domains before and (slightly less) after treatment. Clini-
cians should be aware of these deficits. Researchers should
employ more rigorous methodologies. Better awareness,
early diagnosis and treatment of cognitive deficits may
improve outcome and quality of life in this patient
population.
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